Update on intraepithelial neoplasia of the vulva: Proceedings of a workshop at the 2009 World Congress of the International Society for the Study of Vulvovaginal Diseases, Edinburgh, Scotland, September 2009

Journal of Lower Genital Tract Disease

Volumn 14, Issue 4, 2010, Pages 363-373

  Heller, Debra S ^a   Van Seters, Manon ^b   Marchitelli, Claudia ^c   Moyal Barracco, Michelline ^d   Preti, Mario ^e   Van Beurden, Marc ^f  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^d Hôpital Tarnier Cochin ^*  (France)

^e UNIVERSITY OF TURIN   (Italy)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

carcinoma in situ; intraepithelial neoplasia; Vulvar neoplasms

Indexed keywords

CARCINOMA IN SITU; DISEASE CLASSIFICATION; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; MELANOMA; PAGET SKIN DISEASE; PREVALENCE; REVIEW; VULVA TUMOR; WART VIRUS;

CARCINOMA IN SITU; FEMALE; HIV INFECTIONS; HUMANS; PAPILLOMAVIRUS INFECTIONS; SCOTLAND; VULVAR NEOPLASMS;

EID: 77958120032     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181d95c71     Document Type: Review

References (65)

1. Spitzer M. Lower genital tract neoplasia in HIV-infected women: guidelines for evaluation and management. Obstet Gynecol Surv 1999;54:131-7. (Pubitemid 29062038)
2. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirusYassociated cancers among persons with AIDS. J Natl Cancer Inst 2009;101:1120-30.
3. Abercrombie PD, Korn AP. Vulvar intraepithelial neoplasia (VIN) in HIV-infected women. In: Program Abstr HIV Infect Women Conf HIV Infect Women Conf 1995; February 22-24, 1995; Washington, DC. S59.
4. De Gois NM, Costa RR, Kesselring F, de Freitas VG, Ribalta JC, Kobata MP, et al. Grade 3 vulvar and anal intraepithelial neoplasia in a HIV seropositive childVtherapeutic result: case report. Clin Exp Obstet Gynecol 2005;32:138-40. (Pubitemid 41076090)
5. Korn AP, Abercrombie PD, Foster A. Vulvar intraepithelial neoplasia in women infected with human immunodeficiency virus-1. Gynecol Oncol 1996;61:384-6. (Pubitemid 26169265)
6. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol 2006;107:1023-8. (Pubitemid 43755538)
7. Taube JM, Nichols AD, Bornman LS, Bornman DM, Jackson JB. Langerhans cell density and high grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection. J Cutan Pathol 2007;34:565-70.
8. Dedes KJ, Beneder C, Samartzis N, Muller MD, Fink D, Fehr MK. Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virusYinfected women. J Reprod Med 2008;53:947-51.
9. Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 2004;190:1241-8. (Pubitemid 38692204)
10. Ferenczy A, Coutlee F, Franco E, Hankins C. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ 2003;169:431-4. (Pubitemid 37076256)
11. Todd RW, Luesley DM. Medical management of vulvar intraepithelial neoplasia. J Lower Gen Tract Dis 2005;9: 206-12. (Pubitemid 41437588)
12. Donne AJ, Hampson L, He XT, Rothera MP, Homer JJ, Hampson IN. Cidofovir induces an increase in levels of lowrisk and high-risk HPV E6. Head Neck 2009;31:893-901.
13. Fehr MK, Hornung R, Schwarz VA, Simeon R, Haller U, Wyss P. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gynecol Oncol 2001;80:62-6. (Pubitemid 32062090)
14. Iavazzo C, Pitsouni E, Athanasiou S, Falagas ME. Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia. Int J Gynaecol Obstet 2008;101:3-10.
15. Le T, Menard C, Hicks-Boucher W, Hopkins L, Weberpals J, Fung-Kee-Fung M. Final results of a phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia. Gynecol Oncol 2007;106:579-84. (Pubitemid 47302478)
16. Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double-blinded study. Gynecol Oncol 2007;107:219-22. (Pubitemid 47575715)
17. van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008;358:1465-73. (Pubitemid 351482738)
18. Kenter GG, Welters MJ, Vanlentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 2009;361:1838-47.
19. Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, et al. Vaccinia-expressed human papillomavirus 16 and 18 E6 and E7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res 2003;9:5205-13. (Pubitemid 37413570)
20. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against highgrade vulval and vaginal lesions: a combined analysis of three randomized clinical trials. Lancet 2007;369: 1693-702. (Pubitemid 46783792)
21. Winters U, Daayana S, Lear JT, Tomlinson AE, Elkord E, Stern PL, et al. Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res 2008;14:5292-9.
22. Rouzier R, Morice P, Haie-Meder C, Lhomme C, Avril MF, Duvillard P, et al. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas. Gynecol Oncol 2001;81:414-9. (Pubitemid 32494656)
23. Chafe W, Richards A, Morgan L, Wilkinson E. Unrecognized invasive carcinoma in vulvar intraepithelial neoplasia (VIN). Gynecol Oncol 1988;31:154-65. (Pubitemid 19095772)
24. Van seters M, Van Beurden M, de Craen AJM. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005;97:645-51. (Pubitemid 40614916)
25. Polterauer S, Dressler C, Grimm C, Seebacher V, Temfer C, Reinthaller A, et al. Accuracy of preoperative vulva biopsy and the outcome of surgery in vulvar intraepithelial neoplasia 2 and 3. Int J Gynecol Pathol 2009;28: 559-62.
26. Friedrich EG Jr, Wilkinson EJ, Fu YS. Carcinoma in situ of the vulva: a continuing challenge. Am J Obstet Gynecol 1980;136:830-43.
27. Buscema J, Woodruff JD. Progressive histobiologic alterations in the development of vulvar cancer. Am J Obstet Gynecol 1980;138:146-50.
28. Herod JJ, Shafi MI, Rollason TP, Jordan JA, Luesley DM. Vulvar intraepithelial neoplasia: long-term follow-up of treated and untreated women. Br J Obstet Gynaecol 1996;103:446-52. (Pubitemid 26141634)
29. Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol 1994;84:741-5.
30. Van Beurden M, der Vange N, ten Kate FJ, de Craen AJ, Schilthuis MS, Lammes FB. Restricted surgical management of vulvar intraepithelial neoplasia 3: focus on exclusion of invasion and on relief of symptoms. Int J Gynecol Cancer 1998;8:73-7. (Pubitemid 28119961)
31. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005;106:1319-26.
32. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Lower Gen Tract Dis 2006;10:161-9. (Pubitemid 44618506)
33. Hantschmann P, Sterzer S, Jegchke U, friese K. p53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia, and lichen sclerosus. Anticancer Res 2005;25:1739-45. (Pubitemid 40896796)
34. Maclean AB, Reid WM, Rolfe KJ, Gammell SJ, Pugh He,Gatter KC, et al.Role of angiogenesis in benign, premalignant and malignant vulvar lesions. J Reprod Med 2000;45:609-12.
35. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005;50:807-10. (Pubitemid 41720964)
36. van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 2008;68:131-56.
37. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30.
38. Hoevenaars BM, van der Avoort IA, de Wilde PC, Massuger LF, Melchers WJ, de Hullu JA, et al. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer 2008;123:2767-73.
39. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006;13:8-15. (Pubitemid 44357144)
40. van der Avoort IA, van der Laak JA, Paffen A, Grefte JM, Massuger LF, de Wilde PC, et al. MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Mod Pathol 2007;20:770-8. (Pubitemid 46933448)
41. Mulvany NJ, Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol 2008;27: 125-35.
42. Raspollini MR, Asirelli G, Moncini D, Taddei GL. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol 2007;197:592e1. (Pubitemid 47302475)
43. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000;24:429-41. (Pubitemid 30127480)
44. van de Nieuwenhof HP, Massuger LF, van der Avoort IA, bekkers RL, Casparie M, Abma W, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer 2009;45:851-6.
45. van Beurden M, ten Kate FJ, Smits HL, Berkhout RJ, de Craen AJ, van der Vange N, et al. Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer 1995;75:2879-84.
46. Scurry J, Campion M, Scurry B, Kim SN, Hacker N. Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia. Int J Gynecol Pathol 2006;25:176-81. (Pubitemid 44620182)
47. Eva LJ, Ganesan R, Chan KK, Honest H, Luesley DM. Differentiated-type vulval intraepithelial neoplasia has a highrisk association with vulval squamous cell carcinoma. Int J Gynecol Cancer 2009;19:741-4.
48. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell. carcinomas and associated cutaneous lesions. A correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 2006; 30:310-18. (Pubitemid 43740162)
49. Carlson JA, Lamb P, Malfetano J, Ambros RA, Mihm MC Jr. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 1998;11: 844-54. (Pubitemid 28440881)
50. Jones RW, Sadler L, Grant S, Whineray J, Exeter M, Rowan D. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma. A casecontrol study. J Reprod Med 2004;49:808-11. (Pubitemid 39431177)
51. Jones RW, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinic. Am J Obstet Gynecol 2008;198:496.e1-3. (Pubitemid 351622064)
52. Eva LJ, Ganesan R, Chan KK, Honest H, Malik S, Luesley DM. Vulval squamous cell carcinoma occurring on a background of differentiated vulva intraepithelial neoplasia is more likely to recur. J Reprod Med 2008;53: 397-401. (Pubitemid 351976409)
53. Carli P, Cattaneo A, DeMagnis A, Biggeri A, Taddei G, Giannotti B. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 1995; 4:491-5.
54. Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002;33:549-54.
55. Brown HM, Wilkinson EJ. Uroplakin-III to distinguish primary vulvar Paget disease from Paget disease secondary to urothelial carcinoma. Hum Pathol 2002;33:545-8.
56. Preti M, Michelletii L, Massobrio M, Ansai SI, Wilkinson EJ. Vulvar Paget disease: one century after first reported. J Lower Gen Tract D 2003;7:122-35. (Pubitemid 36469360)
57. Shaco-Levy R, Beam SM, Vollmer RT, Papalas JA, Bentley RC, Selim MA, et al. Paget disease of the vulva: a histologic study of 56 cases correlating pathologic features and disease course. Int J Gynecol Pathol 2010;29:69-78.
58. Ewing T, Sawicki S, Ciaravino G, Runmore GJ. Microinvasive Paget's disease. Gynecol Oncol 2004;95:755-8. (Pubitemid 39592554)
59. Plaza JA, Torres-CabalaC, IvanD, PrietoVG.HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J Cutan Pathol 2009;36:729-33.
60. Hatch KD, Davis JR. Complete resolution of Paget disease of the vulva with imiquimod cream. J Lower Gen Tract Dis 2008;12:90-4.
61. Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, et al. Early diagnosis of cutaneous melanoma revisiting the ABCDE criteria. JAMA 2004;292: 2771-6. (Pubitemid 39628257)
62. Tran KT, Wright NA, Cockerell CJ. Biopsy of the pigmented lesion-when and how. J Am Acad Dermatol 2008;59: 852-71.
63. Dummer R, Hauschild A, Jost L, ESMO Guidelines Working Group. Cutaneous malignant melanoma. ESMO clinical recommendations for diagnosis, treatment, and follow-up. Ann Oncol 2008;19(suppl 2):ii86-8. (Pubitemid 36950163)
64. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, et al. Evidence and interdisciplinary consensus-based German guidelines surgical treatment and radiotherapy of melanoma. Melanoma Res 2008;18: 61-7. (Pubitemid 351628058)
65. Kingston NJ, Jones RW, Baranyai J. Recurrent primary vulvovaginal malignant melanoma arising in melanoma in situVthe natural history of lesions followed for 23 years. Int J Gynecol Cancer 2004;14:628-32. (Pubitemid 39062919)